John H. Eldridge
Chief Tech/Sci/R&D Officer presso Profectus BioSciences, Inc.
Profilo
John H.
Eldridge is currently the Chief Scientific Officer-Vaccines at Profectus BioSciences, Inc. He previously worked as the Vice President-Advanced Vaccines Research at Wyeth LLC.
Prior to that, he was a Faculty Member at The University of Alabama.
Eldridge earned his doctorate degree from the State University of New York at Buffalo in 1981.
Posizioni attive di John H. Eldridge
| Società | Posizione | Inizio |
|---|---|---|
Profectus BioSciences, Inc.
 Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Chief Tech/Sci/R&D Officer | 01/09/2008 |
Precedenti posizioni note di John H. Eldridge
| Società | Posizione | Fine |
|---|---|---|
| The University of Alabama | Corporate Officer/Principal | 01/01/1993 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Formazione di John H. Eldridge
| State University of New York at Buffalo | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Health Technology |
- Borsa valori
- Insiders
- John H. Eldridge
